Search clinical trials for: VTE

Total 274 results

Inger Lise Gade
Aarhus University Hospital Skejby

Completed

Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate (VTE-COVID-19)

Covid19 | Corona Virus Infection

Denmark
Beijing Tsinghua Chang Gung Hospital

Completed

Risk Factors and a nOmogram of Venous thromboEmbolism in Patients After liveR Transplantation(ROVER Study)

Liver Transplantation | Venous Thromboembolism

China
Beijing Chao Yang Hospital

Completed

A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients (VTEH)

Hemorrhage | Venous Thromboembolism

China
University of Maryland, Baltimore

Completed

A Different Approach to Preventing Thrombosis (ADAPT)

Venous Thromboembolism | Pulmonary Embolism

United States
Bayer
Janssen Research & Development, LLC

Completed

Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners (PRACTISE)

Venous Thromboembolism (VTE)

Sweden
Pfizer

Withdrawn

A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment

Pulmonary Embolism | Thrombosis, Deep Vein
Duke University
National Institutes of Health (NIH); National Institute on Aging (NIA); Hartford... and other collaborators

Completed

VTE Prophylaxis Guidelines in Hospitalized Elders

Venous Thromboembolism

United States
COVID-19 Prevention Network

Completed

SARS-CoV-2/COVID-19 Prevalence Study

COVID-19

United States, Puerto Rico
Beijing Tsinghua Chang Gung Hospital

Completed

Venous thromboEmbolism Risk Profiles in Chinese hoSpitalized patiEnts (VERSE Study)

Venous Thromboembolism

China
Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company

Completed

Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease

Niemann-Pick Disease, Type C1

United States
Nantes University Hospital

Terminated

Prospective and Monocentric Study of the Incidence of Venous Thromboembolic Disease (VTE) in Spinal Cord Injury (SCI) Patient Between 3 and 12 Months After SCI (IMATEM)

Spinal Cord Injury

France
Thrombosis Research Institute
Bayer

Completed

Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events (GARFIELD-VTE)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
AIO-Studien-gGmbH
Bayer; Charite University, Berlin, Germany

Terminated

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

Cancer | Venous Thromboembolism

Germany
Centre Hospitalier Universitaire de Saint Etienne

Completed

Predictors of Attempted Inferior Vena Cava Filters Retrieval.

Venous Thromboembolic Disease

France
Vestre Viken Hospital Trust

Terminated

Observational Study of Thrombogenic Properties in 220 Patients With Proximal Femur Fracture (thro-fract15)

Thromboembolism

Norway
Jeffrey Zwicker, MD
National Heart, Lung, and Blood Institute (NHLBI); Quercegen Pharmaceuticals

Completed

Cancer Associated Thrombosis and Isoquercetin (CATIQ) (CATIQ)

Thromboembolism of Vein VTE in Colorectal Cancer | Thromboembolism of Vein in Pancreatic Cancer | Thromboembolism of Vein in Non-small Cell Lung Cancer

United States
Leiden University Medical Center

Terminated

Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual Bleeding (TEAM-VTE)

Venous Thromboembolism

France, Netherlands, Austria, Germany, Switzerland, United Kingdom
Xijing Hospital

Unknown

Management of TA in VaS-Patients and HT

VTE After Stroke

China
Manuel Monreal

Completed

Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses (BLEEDING)

COVID-19

Spain
Manuel Monreal

Completed

Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital (SCREENING)

COVID-19

Spain
China-Japan Friendship Hospital

Unknown

Development and Validation of the Patient-completed Caprini Risk Score

Venous Thromboembolism

China
University Hospital, Brest
Bristol-Myers Squibb

Unknown

Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism. (DEBRIEF-VTE)

Venous Thromboembolism

France
Beijing Friendship Hospital

Unknown

Incidence Rate of Perioperiative VTE in Colorectal Cancer Patients : a Multicenter Prospective Observational Cohort Study

Incidence Rate of Perioperiative Venous Thromboembolism(VTE) in Colorectal Cancer Patients
Ohio State University

Terminated

Statin Use in Patients With Acute VTE

Venous Thromboembolism

United States
Quovadis Associazione
Azienda Ospedaliera di Padova

Completed

Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19 (VTE-COVID)

COVID-19 Disease | Thromboembolism, Venous

Italy
Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company

Withdrawn

Safety and Tolerability Study of VTS-270 in Pediatric Participants With Niemann-Pick Type C (NPC) Disease

Niemann-Pick Disease, Type C
Boehringer Ingelheim

Completed

Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)

Venous Thromboembolism

United States, Spain, Norway, Canada, Belgium, Thailand, Germany, Turkey, Austria, Hungary, Czechia, Taiwan, Israel, Brazil, Denmark, Italy, Lithuania, Russian Federation, Sweden, Switzerland, Ukraine, Mexico, Greece, Argentina, Finland, ...
Baltimore VA Medical Center

Completed

Intermittent Pneumatic Compression of the Upper Extremity for Post-Operative VTE Prophylaxis

Venous Thromboses
Ministry of Health, Saudi Arabia
Universiti Sains Malaysia; Prince Sultan Military College of Health Sciences

Completed

Risk Stratification Procedure for Thromboembolism Prophylaxis

Total Knee Replacement Surgeries

Saudi Arabia
Huashan Hospital

Completed

Study of Venous Thromboembolism Risk Profiles and Prophylaxis in Neurosurgical Inpatients (VTE)

Venous Thromboembolism

China
Daiichi Sankyo, Inc.

Completed

Edoxaban Management in Diagnostic and Therapeutic Procedures (EMIT-AF/VTE)

Atrial Fibrillation | Venous Thromboembolism
Germans Trias i Pujol Hospital

Completed

Switching From Protease Inhibitor (PI) to Etravirine in HIV-1 Infected Subjects With Viremia Suppression

HIV

Spain
Johns Hopkins University
Patient-Centered Outcomes Research Institute

Completed

Education Bundle to Decrease Patient Refusal of VTE Prophylaxis

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis

United States
Daiichi Sankyo, Inc.

Completed

Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN)

Venous Thromboembolism

Taiwan, Korea, Republic of
Tongji Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study) (Neptune)

Chronic Hepatitis b
LEO Pharma

Completed

Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE) (PREDICARE)

Venous Thromboembolism

France
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery (TEXT-TKR)

VTE Prophylaxis With Anticoagulation After Total Knee Replacement Surgery

Belgium, Italy, Malaysia, Latvia, Spain, Turkey, Bulgaria, United States, Lithuania, Russian Federation, Ukraine, Japan, Argentina, Brazil, Canada, Poland
Second Affiliated Hospital, School of Medicine,...

Unknown

A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE)

Venous Thromboembolism | Anticoagulants and Bleeding Disorders | Foot Ankle Injuries

China
University of Miami

Terminated

Aspirin and Enoxaparin for VTE in Trauma

Trauma | Venous Thromboembolism | Thromboprophylaxis

United States
Bristol-Myers Squibb

Completed

A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the US

Venous Thromboembolism (VTE)

United States
Cardioangiologisches Centrum Bethanien

Completed

Substudy - Evaluation of Patients With Iliac Vein Thrombosis

Iliac Vein Thrombosis

Germany
National Institute of Allergy and Infectious Diseases...

Completed

H5N1 Vaccination With and Without AS03: Systems Biology Analysis

Influenza

United States
Sunshine Lake Pharma Co., Ltd.

Completed

A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects

Chronic Hepatitis B

China
Janssen Research & Development, LLC
Bayer

Completed

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Neoplasms

United States, France, United Kingdom, Germany, Belgium, Bulgaria, Canada, Brazil, Russian Federation, Czechia
M.D. Anderson Cancer Center

Unknown

Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans

Cancer | Venous Thromboembolism

United States
Bayer
Janssen Research & Development, LLC

Completed

Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy (XALIA LEA)

Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE)

Turkey, Russian Federation, Korea, Republic of, Mexico, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Egypt, Kazakhstan, Algeria, Lebanon, Saudi Arabia, Ukraine, Jordan, Kenya, Kuwait, Morocco, Qatar, United Arab Emirates
Loyola University

Withdrawn

Timing of VTE Prophylaxis in TBI

TBI (Traumatic Brain Injury) | VTE (Venous Thromboembolism)

United States
Allergan

Completed

A Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula

Age-related Volume Deficit in the Mid-face

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Long-term Outcome After Edoxaban Versus Vitamin K Antagonists for Acute VTE (HOKUSAIpostVTE)

Quality of Life | Post Thrombotic Syndrome | Chronic Thromboembolic Pulmonary Hypertension | Venous Thromboembolic Disease

Netherlands
Johns Hopkins University
GlaxoSmithKline

Completed

Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients

Pulmonary Embolism | Deep Venous Thrombosis

United States

Search clinical trials for: VTE

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations